Superluminal Medicines vs Alphabet Inc.
Side-by-side comparison of AI visibility scores, market position, and capabilities
Boston AI GPCR drug discovery with $1.3B Eli Lilly collaboration Aug 2025 for obesity/cardiometabolic; $158M total ($120M RA Capital/Insight/NVIDIA/Lilly Series A Sep 2024) with MC4R obesity program advancing to IND competing with Relay Therapeutics.
About
Superluminal Medicines is a Boston-based biotechnology company — backed with approximately $158 million in total funding including a $33 million seed in 2023 and a $120 million Series A in September 2024 led by RA Capital Management with Insight Partners, NVIDIA's NVentures, and Eli Lilly — developing AI-driven small molecule drugs targeting G protein-coupled receptors (GPCRs), combining artificial intelligence, protein dynamics simulation, and structural biology to discover drugs for 70% of GPCRs that currently remain "undruggable" despite GPCRs representing the target class for approximately 35% of all FDA-approved drugs. In August 2025, Superluminal secured a landmark $1.3 billion collaboration agreement with Eli Lilly to discover small molecule therapeutics for obesity and cardiometabolic diseases, and is advancing its lead internal MC4R agonist program (for obesity treatment) toward IND-enabling studies with human trials expected Q4 2026. Founded in 2022.
Mountain View AI and digital advertising conglomerate (NASDAQ: GOOGL) $350B FY2024 revenue (+15%); Google Search 90%+ share, Google Cloud $43.2B (+30%), Gemini AI, DOJ monopoly ruling 2024.
About
Alphabet Inc. is a Mountain View, California-based technology conglomerate — publicly traded on the NASDAQ (NASDAQ: GOOGL, GOOG) as an S&P 500 Information Technology component — operating as the holding company for Google (Search, YouTube, Google Ads, Gmail, Google Cloud, Android, Chrome, Maps, Play Store, Workspace), and Other Bets (Waymo autonomous vehicles, DeepMind AI research, Verily life sciences, Wing drone delivery, Google Fiber) through approximately 183,000 full-time employees. In fiscal year 2024, Alphabet reported revenues of $350 billion (+15% year-over-year), with Google Services (Search, YouTube, Google Play, subscriptions) generating $307 billion, Google Cloud generating $43.2 billion (+30%), and Other Bets $2.0 billion, while generating $100 billion in net income — reflecting Alphabet's position as one of the highest-profit companies in history, funded by Google Search's advertising monopoly (processing 8.5+ billion searches daily, commanding 90%+ global search market share). CEO Sundar Pichai has prioritized Alphabet's AI-first transformation: the 2024 launch of Gemini Ultra 1.0, Gemini 1.5 Pro (1 million token context window — largest at launch), and Gemini 2.0 Flash positioned Google as a competitive AI frontier model lab alongside OpenAI, following the ChatGPT disruption that temporarily threatened Google's search advertising dominance in 2023. Google Cloud's Vertex AI platform (enterprise AI model deployment with Gemini, Llama, and third-party models) and Google Distributed Cloud (air-gapped government cloud) compete directly with Microsoft Azure AI and AWS SageMaker for enterprise AI workload contracts. Waymo's commercial robotaxi operations in San Francisco, Phoenix, and Los Angeles (Waymo One — fully driverless rides, generating revenue and operational data) represent Alphabet's highest-upside long-duration investment.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.